Spevigo Becomes First Treatment Option for Generalized Pustular Psoriasis Flares
XTalks
SEPTEMBER 22, 2022
GPP occurs in individuals with specific gene variations as it is a genetic disease , and variations in the genes IL36RN and AP1S3 are known to cause it. The novel, selective monoclonal antibody spesolimab behind Spevigo reduces flares in individuals by inhibiting interleukin-36 (IL-36) signalling.
Let's personalize your content